NDC 70771-1708-01 - BORTEZOMIB

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 70771-1708
Requested NDC: 70771-1708-01
Package NDCs from labels: 70771-1708-1, 70771-1708-01
Manufacturer: Zydus Lifesciences Limited | Zydus Hospira Oncology Private Limited
Effective date: 2022-05-05
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
BORTEZOMIB - Zydus Lifesciences Limited \| Zydus Hospira Oncology Private Limited	Zydus Lifesciences Limited \| Zydus Hospira Oncology Private Limited	2022-05-05	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70771-1708-1	BORTEZOMIB	3.5 mL in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, LYOPHILIZED,	3.5		1
70771-1708-1	BORTEZOMIB	1 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70771-1708	BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS LIFESCIENCES LIMITED]	1	Current NDC, Legacy NDC, 2 package rows	20220505_582c7c0d-fa25-4586-8157-a1e2653d72d9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 3 · 41 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bortezomib	BORTEZOMIB	MAIA Pharmaceuticals, Inc.	c40e6a28-d577-43d4-bca6-bef28da1d580	2021-09-22	Warnings, Adverse reactions	Exact identifier unii: 69G8BD63PP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.